The Board of Trustees of the Leland Stanford Junior University
发明人:
申请号：
EP19163809.7
公开号：
EP3553087A1
申请日:
2015.01.08
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Methods are provided for treatment of lung cancers, particularly small cell lung cancer with targeted therapy. The therapy is targeted at one or more cell-surface antigens, including CD24, CD166, CD56, CD326, CD298, CD29, CD63, CD9, CD164, CD99, CD46, CD59, CD57, CD165, and EpCAM, which optionally includes an agent that selectively blocks CD47 binding to SIRPa.
